CELSENTRI bør derfor anvendes med forsigtighed til patienter med nedsat nyrefunktion (CLcr < 80 ml/ min, der samtidigt anvender CYP3A4- hæmmere.
Therefore, CELSENTRI should be used with caution in patients with renal impairment (CLcr < 80 ml/ min) who are also taking potent CYP3A4 inhibitors.